Biological interactions between human cytomegalovirus (HCMV) and the human immunodeficiency virus type 1 (HIV-1) were analysed in transfection and infection experiments, carried out in a human osteogenic sarcoma cell line (HOS) and in the same cell line chronically infected with HCMV (E155). When HOS and E155 cells were transfected with recombinant plasmids containing the HIV long terminal repeat (LTR) linked to the bacterial chloramphenicol acetyltransferase (CAT) gene, LTR-directed CAT expression was 20 times higher in E155 cells than in HOS cells. HOS cells co-infected with HCMV and HIV-1 showed enhanced production of the HIV-1 p24 antigen. In reciprocal experiments, an increase in HCMV immediate early gene expression was observed when HCMVinfected HOS cells and E155 cells were either transfected with a recombinant plasmid containing the HIV transactivator gene (pTAT), or when infected with HIV-1. DNA hybridization analysis of E155 and HCMV-infected HOS cells revealed higher levels of HCMV DNA in cells transfected with pTAT than in ceils transfected with other non-specific recombinant plasmids. E155 cells transfected with pTAT also produced higher titres of infectious HCMV than control cultures of E155 cells transfected with other recombinant plasmids, including pMTAT carrying a mutant tat gene. The functional reciprocity in vitro between HCMV and HIV is discussed with respect to its possible implications for the clinical development of AIDS.
Introduction
AIDS and related immunological disorders have been aetiologically linked to human immunodeficiency virus type 1 (HIV-1) (Gallo et al., 1984; Levy et al., 1984; Curran et al., 1985) . AIDS patients are often latently infected for months or years before overt symptoms appear, so much interest has centred on the factors that trigger or complement active HIV-1 infection. One possibility is co-infection with other viruses, especially herpesviruses. Several studies have demonstrated the ability of secondary infectious agents to trigger HIV growth in vitro (Gendelman et al., 1986; Zagury et al., 1986; Mosca et al., 1987; Rando et al., 1987; Horvat et al., 1989) . Clinical findings have served to focus attention on human cytomegalovirus (HCMV), an opportunistic pathogen that has been detected in a number of different immunodeficiency syndromes, including AIDS (Macher et al., 1983; Mintz et al., 1983) and HCMV viraemia parallels the progression of AIDS symptoms (Fiala et al., 1986 ). An increased titre of HCMV antibody is observed as a significant indicator of 0000-9032 © 1990 SGM the development of AIDS in HIV-seropositive homosexual men (Polk et al., 1987) and in some cases, multiple isolates of HCMV have been detected in HIV-infected patients (Drew et al., 1984; Spector et al., 1984) . HIV and HCMV can co-infect brain cells of AIDS patients (Nelson et aL, 1988) and AIDS victims, in their terminal state, have overwhelming disseminated HCMV infections (Macher et al., 1983) .
HCMV, like HIV, can be transmitted both sexually and via blood transfusions and can infect both lymphocytes and monocytes (Rice et al., 1984) , which are also the target cells for HIV-1 infection. HCMV infection alone can depress T lymphocyte helper/suppressor ratios (Drew et al., 1985) and, in allograft recipients, leads to a high incidence of opportunistic infections as well as graft rejection (Rubin et al., 1977; Hirsch & Felsenstein, 1984) . This observation raises the possibility that immune suppression induced by one virus favours replication of another virus, with concomitant enhancement of the immunosuppressive capability of the second virus.
Molecular analyses have indicated that HCMV (or the W.-Z. Ho and others immediate early genes of HCMV) can increase HIV long terminal repeat (LTR)-directed transcription (Davis et al., 1987; Elfassi et al., 1987; Rando et al., 1987; Skolnik et al., 1988) . In the present study, we have further analysed the molecular interactions of HCMV and HIV-1. We report that HCMV enhances HIV-1 transcription and the production of p24a,0 protein in fibroblastoid cell lines, and that HIV-1 and its tat gene are capable of enhancing the expression of immediate early proteins and the full replication of HCMV in these cells. These results suggest a functional complementarity of these viruses that might be reflected in vivo during the development of AIDS.
Methods
Cell lines and viruses. The human osteogenic sarcoma (HOS) clonal cells (TE-85, clone F-5) derived from a 13 year old Caucasian female (Rhim et al., 1975) were obtained from C. J. Chern (The Wistar Institute). The HOS and the HCMV chronically infected HOS cells (E 155) (Furukawa et al., 1981) were grown in Eagle's modified minimal essential medium, supplemented with vitamins, glutamine and 7.5% foetal calf serum. The E 155 cell line consistently yields HCMV titres of 102 to 1~ p.f.u, per ml of culture medium (Furukawa et aL, 1981) . HOS and E155 cells were demonstrated, by karyotypic analysis, to contain only human chromosomes and to lack HeLa markers. Immunohistochemical tests (Osborn et al., 1984) confirmed the mesenchymal origin of the cell lines. HOS and E 155 cells do not express the CD4 molecule, as assayed using a monoclonal antibody (MAb) directed against the OKT4 and OKT4a epitopes (Ortho Diagnostic Systems) and flow cytofluorimetry (Ho et al., unpublished data; S. Bandyopadhyay, The Wistar Institute, personal communication; Tateno et al., 1989) . HCMV (Towne strain) infectivity was assayed, as described by Wentworth & French (1970) , using a human diploid fibroblast cell line (MRC-5) between passages 20 and 30. The virus stock contained 2 × 106 p.f.u, per ml. HIV-I-IIIb strain was propagated in SUPT-1 cells, as reported previously (Hoxie et al., 1986) and the virus stock contained 104 to l0 s TCID5o per ml.
Recombinant plasmids. The HIV recombinant plasmid pLTRchioramphenicol acetyltransferase (CAT) contains portions of the HIV-LTR (-452 to +80 base pairs, relative to the mRNA start site) linked to the CAT gene (Rando et al. 1987) . The HIV tat gene construct, pTAT, contains the tat gene (Sanchez-Pescador et al., 1985) positioned between the simian virus 40 (SV40) early promoter and polyadenylation signals (Peterlin et al., 1986) . Mutant tat-containing plasmid (pMTAT) was constructed by cleaving the HIV proviral DNA, pZ6Neo with BamHI restriction enzyme and subsequently cloning it into SV40 early promoter expression vector pKSV10. This construct, which is devoid of the tat initiation codon, lacked transactivation capability in cotransfection experiments with pLTR-CAT in HOS and HeLa cells (data not shown). The HIV art gene construct, pART (or pREV) obtained from D. M. Knight (Centacor), has been described (Knight et al., 1987) . The recombinant plasmid pRL43a, which contains the HCMV immediate early (IE) genes 1 and 2, was obtained from G. Hayward (The Johns Hopkins University, School of Medicine, Baltimore, Maryland, U.S.A.) and has been described in detail (Pizzorno et al., 1988) . The pBR322 control plasmid was purchased from BRL. ] on day 2 after exposure to the second virus and assayed for the 68000 Mr HCMV IE protein by an immunofluorescence (IF) assay, using MAb E-13 (Chemicon International), which specifically detects this protein (Colimon et al., 1984) and a fluorescein isothiocyanateconjugated goat anti-mouse IgG (Cappel Laboratories) as described (Ho & Plotkin, 1987) . Slides were viewed under a Leitz-Wetzlar Ortholux fluorescence microscope at 500-fold magnification, and 2000 cells were counted from each slide.
In a second set of experiments, HCMV-infected HOS, or uninfected HOS cells, grown in 25 cm 2 flasks were incubated with HIV-1 overnight at 36 °C. Inoculum was removed and the cells were washed twice in PBS and trypsinized, cultures were then fed and maintained at 36 °C. Supernatants were collected at 2 h after trypsinization and at various time points thereafter (see Results) and assayed for residual inoculum using a commercial antigen-capture assay for p24~ (DuPont). After 6 days, cells were again trypsinized and co-cultivated with 1 x 104 indicator SUPT-1 cells and monitored for c.p.e. The specificity of c.p.e, was confirmed by the antigen-capture assay.
DNA transfection and transient gene expression assays.
HOS and E 155 cells(5 x 105 in a 60 mm dish) were transfected with caesium chloridepurified plasmid DNA (1 to 10 ~tg) using the calcium phosphate coprecipitation technique (Graham & van der Eb, 1973) . The amount of transfected DNA in each experiment was adjusted to 30 ~tg using sonicated salmon testes DNA. At 4 to 6 h post-transfection, cells were treated with 15% glycerol for 2 min. Transfection efficiency in E155 and HOS cells was monitored by Southern blot hybridization analysis using a pLTR-CAT DNA probe. Cells were re-fed with fresh medium at 24 h post-transfection and assayed for CAT activity, as described (Gorman et al., 1982) , for the indicated time periods before the addition of ethylacetate. Reaction products were separated by ascending thinlayer chromatography and quantified by liquid scintillation counting.
To assay the expression of the HCMV IE proteins, cultured cells were harvested from individual dishes 2 days after transfection with different recombinant plasmids and resuspended at 2 x 105 cells/ml in PBS. Samples (100 [al) of this suspension were dispersed on glass slides using a cytospin centrifuge, and indirect IF was performed, as described earlier.
Analysis of viral DNA. Total DNA was extracted as described (Rando et al., 1986) from E155 cells at 48 h post-transfection. Total DNA was also extracted from HOS cells infected with HCMV (at an m.o.i, of 1 to 2) 16 h before transfection with the same recombinant plasmids. Purified DNA was denatured in 0.4 M-NaOH for 10 min at room temperature, cooled on ice for 5 min and neutralized by the addition of an equal volume of 2 M-sodium acetate pH 5.5. Various dilutions of each denatured DNA sample were immobilized on nitrocellulose filter membranes using a 96-well filtration manifold (Schleicher & Schuell) and dried in vacuo at 80 °C for 2 h, before prehybridizing the samples at 68 °C in 6 x SSC, 0-5% SDS, 5 x Denhardt's buffer and salmon testes DNA (100 ~tg/ml). Samples were hybridized overnight at 68 °C with a 32p-labelled HCMV DNA probe (3.5 × 106 c.p.m./ml), using the same buffer as in the prehybridization step. The HCMV probe was obtained by electrophoretic fractionation of BamHI-restricted pRL43a fragments in a 0.8% low melting temperature agarose get and phenol-chloroform extraction of the 5.1 kb fragment, which contains only DNA sequences corresponding to the HCMV IE gene region (Pizzorno et al., 1988) . Nitrocellulose filters were washed in a solution containing 0.1% SSC and 0.5% SDS at 68 °C for 2 h and air-dried before autoradiography. Radioactivity was quantified by liquid scintillation counting.
Results

H C M V increases H I V LTR-directed gene expression and H I V p24 antigen production
Basal levels of C A T activity in E155 ceils transfected with p L T R -C A T were 21.5-fold higher than in comparable transfected HOS cells (Fig. 1) . The C A T assay, after cotransfection of both cell lines with p L T R -C A T and the control pBR322 plasmid, also revealed significantly higher enzyme activity in E155 cells (35-fold) than in HOS cells (Fig. 1) . High C A T activity observed after cotransfection with p L T R -C A T and p T A T confirmed the ability of p L T R -C A T in both cell lines to be transactivated. Transfection efficiency in both cell lines was comparable as detected by a Southern blot assay. Fig. 2 shows the results of experiments in which HOS cells were infected with HIV-1 alone or in combination with H C M V and the level of p24 antigen in the culture supernatant was monitored daily up to 6 days p.i. The level of detectable p24 antigen was increased in the coinfected ceils, with peak levels at 4 to 5 days post-coinfection, as compared with ceils infected with HIV alone. Expression of p24aa9 protein in 1 to 2% of acetonefixed cells was confirmed by IF.
Production of infectious HIV-1 by the HOS cells was assessed by cocultivation with the SUPT-1 indicator cell line. Development of c.p.e, was monitored, recorded and then confirmed by p24g~ antigen-capture assay. HOS ceils infected with HIV-1 alone or co-infected with HIV-1 and H C M V were able to produce infectious virus.
HIV-1 and its tat gene increase HCMV-IE DNA replication and its expression
Hybridization of a molecular probe specific for the H C M V IE gene region with the total D N A isolated from HCMV-infected HOS cells and from E 155 cells 48 h after transfection with 5 ~tg of pTAT, pART, pBR322 or salmon testes D N A revealed a measurable increase (twoto threefold) in the amount of H C M V IE D N A present in cells transfected with p T A T (Fig. 3a, b) .
HOS ceils infected with either HIV-1 or H C M V and then co-infected with the opposite virus 4 days later showed a 5-9-and 7-5-fold increase, respectively, in the frequency of cells positive for the H C M V -I E 68 000 Mr protein, as compared with H C M V singly infected cells when assayed by IF 2 days after tlae second viral infection (Table 1 , experimental conditions 1 and 2). Similar analysis after dual infections allowed to proceed for 11 days after initial H C M V infection indicated a twoto threefold higher frequency than in the control cultures (data not shown).
HOS cells were also infected with H C M V , transfected 16 h later with 10 ~tg of pTAT, pART, pBR322 or HOS cells were infected with HCMV 16 h before transfection with pTAT, pART, pBR322 or salmon testes DNA. § Ten ktg of pRL43a was cotransfected into HOS cells along with 10 Ixg of pTAT, pART, pBR322 or salmon testes DNA. sonicated salmon testes DNA and assayed for the presence of the HCMV IE proteins by IF 2 days after transfection (Table 1, experimental condition 3) . In similar experiments, HOS cells were cotransfected with 10 p.g of pRL43a, which contains the HCMV IE genes, and 10~tg of the plasmid DNAs above (Table 1 , experimental condition 4). In all of the experimental conditions, the frequency of HOS cells positive for the HCMV IE 68000 Mr protein was enhanced after infection with HIV-1 or transfection with pTAT, compared with the respective controls. The co-infection experiments were each performed four times and the cotransfection experiments 10 times, with similar results.
Table 1. Effects of HIV on the number of H C M V IE protein-positive HOS cells
HIV-tat gene increases infectious H C M V production
Culture supernatant from E155 cells was used in infectivity studies to determine whether HIV-1 gene products affected the yield of infectious HCMV from E155 cells. Cell-free supernatants, obtained from E 155 cells 2 days after transfection with 5 ~tg of pTAT, pMTAT, LTR-CAT, pART, pBR322 or sonicated salmon testes DNA, were incubated with MRC-5 cells under agar overlay and HCMV-induced plaques were counted 10 days later. About 6 to 10 times more infectious HCMV was obtained using supernatant from pTAT-transfected E155 cells than with supernatants derived from the other transfections, including the pMTAT ( Table 2 ). The experiment was repeated four times under identical conditions, with similar results.
Discussion
In this study, we found that HIV-1 or its tat gene product augmented expression of the HCMV IE gene and that the HIV-1 tat gene product increased titres of infectious HCMV in E155 cells and levels of HCMV DNA in E155 cells and in HCMV-infected HOS cells. A slight increase in HCMV replication in a T lymphoblastoid cell line persistently infected with HIV was also demonstrated recently (Casareale et al., 1989) . By contrast, Skolnik et al. (1988) reported that a Jurkat cell line constitutively expressing the HIV-I tat gene did not increase detectable levels of HCMV DNA, nor did the HIV-1 tat gene in a vaccinia virus recombinant construct increase detectable levels of particular HCMV early proteins in human embryonic lung cells. Possibly, the tat-induced increase observed in HCMV IE gene expression and in the HCMV viral titres is mediated by a cellular intermediate, induced by the tat gene product in HOS and E155 ceils, rather than the result of a direct interaction between HIV-i gene products and HCMV. However, in the study by Skolnik et al. (I988) , expression of HCMV IE proteins was not described and the magnitude of expression of the HCMV late proteins with and without HIV-1 infection was six to 12 cells and 10 to 20 cells (0-03 to 0.06~ and 0.05 to 0.1~o of total cell number), respectively; cell numbers that are difficult to interpret. Consistent with previous reports (Rando et al., 1987; Elfassi et al., 1987) , we also find that HCMV can enhance HIV-1 LTR-directed transcription. The HCMV IE gene region encodes several different proteins (Stinski et al., 1983; Stenberg et al., 1984) and recent evidence has implicated the IE 2 gene in a number of trans-activating and autoregulating events (Hermiston et al., 1987; Pizzorno et al., 1988) , including activation of HIV-I LTR-directed transcription (Davis et al., 1987; Rando et al., unpublished results) . The isolation of HIV from peripheral blood leukocytes usually requires an exogenous signal associated with T-cell activation (Zagury et al., 1986 ) and the enhancer region of the HIV-LTR contains a recognition sequence for the transcriptional factor NF-kB, which is associated with T cell activation (Nabel & Baltimore, 1987) . Gimble et al. (1988) have recently described the induction of a nuclear factor that binds to the NF-kB recognition sequence when HeLa cells are infected with herpes simplex virus type 1. It is possible that HCMV enhances expression of NF-kB or other transcriptional factors, thereby enhancing HIV-LTR expression. We also observed increased levels of HIV-I p24 antigen in the culture medium of HOS cells co-infected with HIV-1 and HCMV, although there was no real change in the time course of detection of p24 antigen during the 6 days p.i.
HIV infection of HOS and E 155 cells, neither of which express the CD4 antigen, strongly suggests an alternative pathway for infection of human fibroblastoid cells. These cells then join the growing list of CD4-negative, HIV-infeetible cell types, including colorectal (Adachi et al., 1987) , glial (Cheng-Mayer et al., 1987) , fibroblastoid (Tateno et al., 1989 ) and neuronal cells (Harouse et al., 1989) . The E155 cell line was developed by serial passages of HCMV-infected HOS cells over 2 years (Furukawa et al., 1981) and maintained in our laboratory for more than 5 years. E155 cells constantly produce HCMV proteins in 5 to 80~ of cells (higher expression if the cells are split more than once in 7 to 10 days) and a low level of infectious virus. The site of HCMV latency in vivo is not clear, but peripheral mononuclear cells (Rice et al., 1984) , kidney mesangial cells (Heieren et al., 1988) and liver cells (Singh et al., 1988) have all been implicated. Infection of E155 cells with HIV-1 might mimic the situation in vivo; some cells harbour the HCMV genome in inactive or replicating form and superinfection of these cells with HIV-1 leads to more productive replication of both viruses.
About 80 to 90 ~ of acutely HCMV-infected HOS cells expressed IE proteins, using an m.o.i, of 10 to 15, but only 1 to 2~ of the cells expressed late proteins, as detected by the IF assay, using a MAb to the major matrix late proteins. No infectious virus production was detectable in the cells (data not shown). It will be of interest to determine whether HIV-1 infection can turn the non-productive HCMV infection into a productive one.
The present studies in HOS and E155 cells not only indicate a broadened host-range of HIV-1 infection, but also provide a cell system in which at least some of the HIV-t and HCMV genes are expressed well, enabling detailed analysis of the molecular and biological interactions between these viruses.
